190 related articles for article (PubMed ID: 33493547)
1. Appetitive, antinociceptive, and hypothermic effects of vaped and injected Δ-9-tetrahydrocannabinol (THC) in rats: exposure and dose-effect comparisons by strain and sex.
Moore CF; Davis CM; Harvey EL; Taffe MA; Weerts EM
Pharmacol Biochem Behav; 2021 Mar; 202():173116. PubMed ID: 33493547
[TBL] [Abstract][Full Text] [Related]
2. Effects of Δ⁹-tetrahydrocannabinol (THC) vapor inhalation in Sprague-Dawley and Wistar rats.
Taffe MA; Creehan KM; Vandewater SA; Kerr TM; Cole M
Exp Clin Psychopharmacol; 2021 Feb; 29(1):1-13. PubMed ID: 32297788
[TBL] [Abstract][Full Text] [Related]
3. Tolerance to hypothermic and antinoceptive effects of ∆9-tetrahydrocannabinol (THC) vapor inhalation in rats.
Nguyen JD; Grant Y; Kerr TM; Gutierrez A; Cole M; Taffe MA
Pharmacol Biochem Behav; 2018 Sep; 172():33-38. PubMed ID: 30031028
[TBL] [Abstract][Full Text] [Related]
4. Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats.
Javadi-Paydar M; Nguyen JD; Kerr TM; Grant Y; Vandewater SA; Cole M; Taffe MA
Psychopharmacology (Berl); 2018 Sep; 235(9):2541-2557. PubMed ID: 29907926
[TBL] [Abstract][Full Text] [Related]
5. Explication of CB
Nguyen JD; Creehan KM; Grant Y; Vandewater SA; Kerr TM; Taffe MA
Drug Alcohol Depend; 2020 Sep; 214():108166. PubMed ID: 32717503
[TBL] [Abstract][Full Text] [Related]
6. Inhaled delivery of Δ(9)-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology.
Nguyen JD; Aarde SM; Vandewater SA; Grant Y; Stouffer DG; Parsons LH; Cole M; Taffe MA
Neuropharmacology; 2016 Oct; 109():112-120. PubMed ID: 27256501
[TBL] [Abstract][Full Text] [Related]
7. Vapor inhalation of cannabidiol (CBD) in rats.
Javadi-Paydar M; Creehan KM; Kerr TM; Taffe MA
Pharmacol Biochem Behav; 2019 Sep; 184():172741. PubMed ID: 31336109
[TBL] [Abstract][Full Text] [Related]
8. Vapor exposure to Δ9-tetrahydrocannabinol (THC) slows locomotion of the Maine lobster (Homarus americanus).
Gutierrez A; Creehan KM; Turner ML; Tran RN; Kerr TM; Nguyen JD; Taffe MA
Pharmacol Biochem Behav; 2021 Aug; 207():173222. PubMed ID: 34197845
[TBL] [Abstract][Full Text] [Related]
9. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part I: development and validation of a pulmonary cannabinoid route of exposure for experimental pharmacology studies in rodents.
Manwell LA; Charchoglyan A; Brewer D; Matthews BA; Heipel H; Mallet PE
J Pharmacol Toxicol Methods; 2014; 70(1):120-7. PubMed ID: 24973534
[TBL] [Abstract][Full Text] [Related]
10. Δ
Nguyen JD; Grant Y; Creehan KM; Hwang CS; Vandewater SA; Janda KD; Cole M; Taffe MA
Neuropharmacology; 2019 Jun; 151():127-135. PubMed ID: 30980837
[TBL] [Abstract][Full Text] [Related]
11. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part II: comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents.
Manwell LA; Ford B; Matthews BA; Heipel H; Mallet PE
J Pharmacol Toxicol Methods; 2014; 70(1):112-9. PubMed ID: 24956154
[TBL] [Abstract][Full Text] [Related]
12. Lasting effects of repeated ∆
Nguyen JD; Creehan KM; Kerr TM; Taffe MA
Br J Pharmacol; 2020 Jan; 177(1):188-203. PubMed ID: 31478558
[TBL] [Abstract][Full Text] [Related]
13. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
[TBL] [Abstract][Full Text] [Related]
14. Δ
Moore CF; Davis CM; Sempio C; Klawitter J; Christians U; Weerts EM
Cannabis Cannabinoid Res; 2024 Feb; 9(1):111-120. PubMed ID: 36179013
[No Abstract] [Full Text] [Related]
15. Pharmacological effects of acute and repeated administration of Delta(9)-tetrahydrocannabinol in adolescent and adult rats.
Wiley JL; O'connell MM; Tokarz ME; Wright MJ
J Pharmacol Exp Ther; 2007 Mar; 320(3):1097-105. PubMed ID: 17172531
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders.
Fernández-Trapero M; Pérez-Díaz C; Espejo-Porras F; de Lago E; Fernández-Ruiz J
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32054131
[TBL] [Abstract][Full Text] [Related]
17. Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.
Goodwin RS; Gustafson RA; Barnes A; Nebro W; Moolchan ET; Huestis MA
Ther Drug Monit; 2006 Aug; 28(4):545-51. PubMed ID: 16885723
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic properties of aerosolized ("vaped") THC in adolescent male and female rats.
Ruiz CM; Torrens A; Lallai V; Castillo E; Manca L; Martinez MX; Justeson DN; Fowler CD; Piomelli D; Mahler SV
Psychopharmacology (Berl); 2021 Dec; 238(12):3595-3605. PubMed ID: 34495367
[TBL] [Abstract][Full Text] [Related]
19. In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: inhalation versus intraperitoneal injection.
Marshell R; Kearney-Ramos T; Brents LK; Hyatt WS; Tai S; Prather PL; Fantegrossi WE
Pharmacol Biochem Behav; 2014 Sep; 124():40-7. PubMed ID: 24857780
[TBL] [Abstract][Full Text] [Related]
20. Effects of combined THC and heroin vapor inhalation in rats.
Gutierrez A; Nguyen JD; Creehan KM; Javadi-Paydar M; Grant Y; Taffe MA
Psychopharmacology (Berl); 2022 May; 239(5):1321-1335. PubMed ID: 34160641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
